AbCellera and Eli Lilly have announced their partnership to develop, manufacture and distribute antibody treatments for the COVID-19 coronavirus.
List view / Grid view
Movers and Shakers
New research has revealed that despite a rising number of women in STEM publishing papers, there is a large gender difference due to females leaving academia.
Here, the benefits of collaborating in drug discovery are explored through the strategic alliance between ELRIG and the British Pharmacological Society.
Boris Johnson, the Prime Minister of the UK, has announced a new Global Talent visa for researchers and scientists which will fast track those in certain fields.
The two organisations have entered into a two-year alliance to improve scientific exchange in the drug discovery industry.
Drug Target Review are pleased to welcome Mike Stones, Managing Editor, to the team...
The University of Zurich is launching a new WHO Collaborating Centre for Physical Activity and Health. The Physical Activity and Health Unit and other groups of the Epidemiology, Biostatistics and Prevention Institute will support the Physical Activity Strategy for the World Health Organization (WHO) European Region.
Kymab Group Limited, a leading human monoclonal antibody biopharmaceutical group, announces the appointment of Dr Sonia Quaratino as its first Chief Medical Officer. Dr Quaratino will manage the clinical development of the Group's expanding therapeutic antibody portfolio.
The biotechnology company Genmab announced today the appointment of Judith Klimovsky, MD, as Executive Vice President and Chief Development Officer.
Enterome is pleased to announce the appointments of Jai Patel, PhD as Chief Medical Officer and Roger Garceau, MD as non-executive Director.